Clover Health Investments, Corp.
CLOV
$2.69
$0.020.75%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -730.30% | 94.23% | -141.31% | -223.58% | 138.64% |
Total Depreciation and Amortization | -15.45% | 35.47% | 1.47% | 2.73% | 3.77% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -5.21% | 365.70% | -136.20% | 6.54% | 27.81% |
Change in Net Operating Assets | 77.31% | 22.41% | -273.15% | 180.04% | -54.55% |
Cash from Operations | 133.19% | 81.02% | -271.71% | 11.68% | 72.57% |
Capital Expenditure | -207.57% | 41.27% | 21.05% | -0.50% | 10.79% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 296.43% | 910.94% | 90.42% | -319.32% | -44.43% |
Cash from Investing | 298.28% | 720.57% | 88.14% | -344.95% | -46.06% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 226.98% | -67.37% | 199.55% | 856.52% | -- |
Repurchase of Common Stock | 73.50% | -369.94% | -39.17% | -51.83% | 4.20% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 75.54% | -416.87% | -31.61% | -46.04% | 4.88% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 184.92% | 58.14% | -381.49% | -28.66% | 46.46% |